Neuropathy and DFU Prevention to be Highlighted at the ADA’s 84th Scientific Sessions
Articles
Last edit: January 13, 2026
June 17, 2024
When the world’s leading clinicians and researchers gather later this month in Orlando, Florida at ADA’s 84th Scientific Sessions, diabetic peripheral neuropathy and diabetic foot ulcer prevention will be spotlighted. Withings devices have been used in a number of major neuropathy and DFU prevention studies being presented at ADA’s Scientific Sessions as well as other diabetes and neurology conferences this year.
Of note at Scientific Sessions will be the release of findings of the longitudinal study “Combined DPNCheck and SUDOSCAN as a Screening Tool for DPN—The Sheffield Prospective Study.” The results will be shared at 1:15 p.m. EDT in Room W307 immediately following the ADA President’s Select Abstract Presentation. Mohummad Shaan Goonoo of Sheffield Teaching Hospitals and NHS Foundation Trust is scheduled to share the clinical findings.
In addition, Philippe Brunswick, Ph.D. will be presenting a poster at Scientific Sessions on Saturday, June 22 at 12:30 pm in Poster Hall West A4-B2 entitled “Improving Diabetic Foot Ulcer Management with Electrochemical Skin Conductance [Board No. 1803].” Attendees are invited to join Philippe and discuss the results and implications in a small-group setting.
Finally, Withings will be hosting a breakfast for diabetes influencers at 7:00 am EDT on Saturday, June 22 at the Hyatt Regency Orlando hotel next door to the convention center. Participants will be able to dig deeper on the breaking research that will have been presented as well as to experience the Body Pro 2 smart scale for the first time. If you are interested in attending the breakfast, please find more information here.
Interested in partnering with us?
